Ophthalmic compositions comprising polyether substituted polymers
AssigneeJohnson & Johnson Vision Care, Inc.
InventorsFrank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
Life of this patent
Estimating the term…
Abstract
The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
Claims15
An ophthalmic device comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300, wherein the water soluble polymer is incorporated into a hydrogel formulation without significant covalent bonding to the hydrogel.
Dependencies are inferred from the claim text.